Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Blijlevens, Nicole M A  [Clear All Filters]
2024
van Groningen LFJ, van Dorp S, Bremmers MEJ, Fazel S, Roeven MWH, Blijlevens NMA, van der Velden WJFM. Significant impact of antibiotic exposure on GI-GVHD, NRM, and GRFS following allogeneic HCT with non-myeloablative Flu-TBI conditioning. Leuk Lymphoma. 2024:1-8.
2023
Bulthuis MS, van Gennip LLA, Bronkhorst EM, Blijlevens NMA, Huysmans M-CDNJM, van Leeuwen SJM, Thomas RZ. The effect of hematopoietic stem cell transplantation on patient-reported subjective oral dryness: a systematic review focusing on prevalence, severity and distress. Support Care Cancer. 2023;31(8):449.
van Hauten PMM, Hooijmaijers L, Vidal-Manrique M, van der Waart AB, Hobo W, Wu J, Blijlevens NMA, Jansen JH, Walcheck B, Schaap NPM, et al. Engineering of CD34+ progenitor-derived natural killer cells with higher-affinity CD16a for enhanced antibody-dependent cellular cytotoxicity. Cytotherapy. 2023.
Skallsjö K, von Bültzingslöwen I, Hasséus B, Johansson J-E, Öhman J, Raber-Durlacher JE, Huysmans M-CDNJM, Laheij AMGA, van Leeuwen SJM, Hovan AJ, et al. Oral health in patients scheduled for hematopoietic stem cell transplantation in the Orastem study. PLoS One. 2023;18(5):e0285615.
Verhagen NE, Koenderink JB, Blijlevens NMA, Janssen JJWM, Russel FGM. Transporter-Mediated Cellular Distribution of Tyrosine Kinase Inhibitors as a Potential Resistance Mechanism in Chronic Myeloid Leukemia. Pharmaceutics. 2023;15(11).
2019
de Kort EA, de Lil HS, Bremmers MEJ, van Groningen LFJ, Blijlevens NMA, Huls G, Brüggemann RJM, van Dorp S, van der Velden WJFM. Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation. PLoS One. 2019;14(3):e0213913.
2018
Sommer S, Cruijsen M, Claus R, Bertz H, Wäsch R, Marks R, Zeiser R, Bogatyreva L, Blijlevens NMA, May A, et al. Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic hematopoietic cell transplantation. Leuk Res. 2018;72:20-26.
Groth C, van Groningen LFJ, Matos TR, Bremmers ME, Preijers FWMB, Dolstra H, Reicherts C, Schaap NPM, van Hooren EHG, IntHout J, et al. Phase I/II trial of a combination of anti-CD3/CD7 immunotoxins for steroid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant. 2018.
2015
van Groningen LFJ, Liefferink AM, de Haan AFJ, Schaap NPM, J Donnelly P, Blijlevens NMA, van der Velden WJFM. Combination therapy with inolimomab and etanercept for severe steroid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant. 2015.
2014
Braber JBos-den, Potting CMJ, Bronkhorst EM, Huysmans M-CDNJM, Blijlevens NMA. Oral complaints and dental care of haematopoietic stem cell transplant patients: a qualitative survey of patients and their dentists. Support Care Cancer. 2014.